Skip to main content
Top
Published in: Pituitary 2/2008

01-06-2008

Hyperprolactinemia

Authors: Jaspreet Chahal, Janet Schlechte

Published in: Pituitary | Issue 2/2008

Login to get access

Abstract

In several respects prolactin is unique among anterior pituitary hormones. The primary regulation of prolactin secretion is mediated through hypothalamic inhibition, and the diagnosis of hyperprolactinemia can be established without the use of stimulation or suppression tests. Documenting the presence of hyperprolactinemia is not difficult–the challenge is in identifying the cause of the hormone hypersecretion. With immunoradiometric assays falsely low levels of prolactin are occasionally seen in patients with macroadenomas and very high serum prolactin (the hook effect). Macroprolactin should be suspected when a patient with hyperprolactinemia does not present with typical clinical symptoms, and all hyperprolactinemic sera should be screened for macroprolactin. With prolactinomas, prolactin levels generally parallel tumor size. Prolactin secreting macroadenomas are typically associated with levels that exceed 250 μg/l and may exceed 1,000 μg/l. Large non-functioning adenomas also lead to hyperprolactinemia but levels virtually never exceed 94 μg/l. Acquired and isolated prolactin deficiency is rare.
Literature
1.
go back to reference Parker DC, Rossman LG, Vanderlaan EF (1973) Relation of sleep-entrained human prolactin release to REM-NonREM cycles. J Clin Endocrinol Metab 38:646–65132 Parker DC, Rossman LG, Vanderlaan EF (1973) Relation of sleep-entrained human prolactin release to REM-NonREM cycles. J Clin Endocrinol Metab 38:646–65132
2.
go back to reference Sassin JF, Frantz AG, Kapen S, Weitzman ED (1973) The nocturnal rise of human prolactin is dependent upon sleep. J Clin Endocrinol Metab 37:436–440. MedlinePubMed Sassin JF, Frantz AG, Kapen S, Weitzman ED (1973) The nocturnal rise of human prolactin is dependent upon sleep. J Clin Endocrinol Metab 37:436–440. MedlinePubMed
3.
go back to reference Veldhuis JD, Johnson L (1988) Operating characteristics of the hypothalamo-pituitary-gonadal axis in men; circadian, ultradian and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 67:116–123. MedlinePubMed Veldhuis JD, Johnson L (1988) Operating characteristics of the hypothalamo-pituitary-gonadal axis in men; circadian, ultradian and pulsatile release of prolactin and its temporal coupling with luteinizing hormone. J Clin Endocrinol Metab 67:116–123. MedlinePubMed
4.
go back to reference Quigley ME, Ropert JF (1981) Acute prolactin, release triggered by feeding. J Clin Endocrinol Metab 52:1043–1045. MedlinePubMed Quigley ME, Ropert JF (1981) Acute prolactin, release triggered by feeding. J Clin Endocrinol Metab 52:1043–1045. MedlinePubMed
5.
go back to reference Carlson HE, Hyman DB, Blitzer MG (1990) Evidence for an intracerebral action of phenylalanine in stimulation of prolactin secretion: interaction of large neutral amino acid. J Clin Endocrinol Metab 70:814–816. MedlinePubMed Carlson HE, Hyman DB, Blitzer MG (1990) Evidence for an intracerebral action of phenylalanine in stimulation of prolactin secretion: interaction of large neutral amino acid. J Clin Endocrinol Metab 70:814–816. MedlinePubMed
6.
go back to reference Lee PA, Xenakis T, Winer J et al (1976) Puberty in girls: correlation of serum levels of gonadotropins, prolactin, androgens, estrogens and progestins with physical changes. J Clin Endocrinol Metab 43:775–784. MedlinePubMedCrossRef Lee PA, Xenakis T, Winer J et al (1976) Puberty in girls: correlation of serum levels of gonadotropins, prolactin, androgens, estrogens and progestins with physical changes. J Clin Endocrinol Metab 43:775–784. MedlinePubMedCrossRef
7.
go back to reference Blackman MR (1987) Pituitary hormones and aging. Endocrinol Clin N Am 16:981–984 Blackman MR (1987) Pituitary hormones and aging. Endocrinol Clin N Am 16:981–984
8.
go back to reference Iranmesh A, Mulligan T, Veldhuis JD (1998) Mechanism subserving the physiological nocturnal hypoprolactinemia of healthy older men: dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency and interpulse interval—a general clinical research study. J Clin Endocrinol Metab 999:1083–1090 Iranmesh A, Mulligan T, Veldhuis JD (1998) Mechanism subserving the physiological nocturnal hypoprolactinemia of healthy older men: dual decline in prolactin secretory burst mass and basal release with preservation of pulse duration, frequency and interpulse interval—a general clinical research study. J Clin Endocrinol Metab 999:1083–1090
9.
go back to reference Vekeman M, Delvoye P, L’Hermite M et al (1977) Serum prolactin levels during the menstrual cycle. J Clin Endocrinol Metab 44:989–993. Medline Vekeman M, Delvoye P, L’Hermite M et al (1977) Serum prolactin levels during the menstrual cycle. J Clin Endocrinol Metab 44:989–993. Medline
10.
go back to reference Neilly AS, Chard T (1974) Circulating levels of prolactin during the menstrual cycle. Clin Endocrinol (Oxf) 3:105–112. MedlineCrossRef Neilly AS, Chard T (1974) Circulating levels of prolactin during the menstrual cycle. Clin Endocrinol (Oxf) 3:105–112. MedlineCrossRef
11.
go back to reference Tyson JE, Fresen HG (1973) Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women. Am J Obstet Gynecol 116:377–387. MedlinePubMed Tyson JE, Fresen HG (1973) Factors influencing the secretion of human prolactin and growth hormone in menstrual and gestational women. Am J Obstet Gynecol 116:377–387. MedlinePubMed
12.
go back to reference Reyniak JV, Wenof M, Aubert JM et al (1980) Incidence of hyperprolactinemia during oral contraceptive therapy. Obstet Gynecol 55:8–11. MedlinePubMed Reyniak JV, Wenof M, Aubert JM et al (1980) Incidence of hyperprolactinemia during oral contraceptive therapy. Obstet Gynecol 55:8–11. MedlinePubMed
13.
go back to reference Davis JR, Selby C, Jeffcoate WJ (1984) Oral contraceptive agents do not affect serum prolactin in normal women. Clin Endocrinol (Oxf) 20:427–434. MedlineCrossRef Davis JR, Selby C, Jeffcoate WJ (1984) Oral contraceptive agents do not affect serum prolactin in normal women. Clin Endocrinol (Oxf) 20:427–434. MedlineCrossRef
14.
go back to reference Urban RJ (1992) Neuroendocrinology of aging in the male and female. Endocrinol Metab Clin North Am 21:921–931. MedlinePubMed Urban RJ (1992) Neuroendocrinology of aging in the male and female. Endocrinol Metab Clin North Am 21:921–931. MedlinePubMed
15.
go back to reference Reyes FI, Winter JS, Faiman C (1977) Pituitary-ovarian relationships preceding the menopause. A cross-sectional study of serum follicle-stimulated hormone, luteinizing hormone, prolactin, oestradiol and progesterone levels. Am J Obstet Gynecol 129:557–564. MedlinePubMed Reyes FI, Winter JS, Faiman C (1977) Pituitary-ovarian relationships preceding the menopause. A cross-sectional study of serum follicle-stimulated hormone, luteinizing hormone, prolactin, oestradiol and progesterone levels. Am J Obstet Gynecol 129:557–564. MedlinePubMed
17.
go back to reference Touraine P, Deneux C, Plu-Bureau G et al (1998) Hormonal replacement therapy in menopausal women with history of hyperprolactinemia. J Endocrinol Invest 21:732–736. MedlinePubMed Touraine P, Deneux C, Plu-Bureau G et al (1998) Hormonal replacement therapy in menopausal women with history of hyperprolactinemia. J Endocrinol Invest 21:732–736. MedlinePubMed
19.
go back to reference Bonnar J, Franklin M, Nott PN et al (1975) Effect of breast-feeding on pituitary-ovarian function after childbirth. BMJ 4:82–84. MedlinePubMedCrossRef Bonnar J, Franklin M, Nott PN et al (1975) Effect of breast-feeding on pituitary-ovarian function after childbirth. BMJ 4:82–84. MedlinePubMedCrossRef
20.
21.
go back to reference Jarrell J, Franks S, McInnes R et al (1980) Breast examination does not elevate serum prolactin. Fertil Steril 33:49–51. MedlinePubMed Jarrell J, Franks S, McInnes R et al (1980) Breast examination does not elevate serum prolactin. Fertil Steril 33:49–51. MedlinePubMed
23.
go back to reference Muneyyirci DO, Goldstein D, Reyes FI (1989) Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test. N Y State J Med 89:205–208. Medline Muneyyirci DO, Goldstein D, Reyes FI (1989) Diagnosis of stress-related hyperprolactinemia. Evaluation of the hyperprolactinemia rest test. N Y State J Med 89:205–208. Medline
24.
go back to reference Moli RL, Endert E, Fliers E et al (2003) Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia. Neth J Med 71:44–48 Moli RL, Endert E, Fliers E et al (2003) Evaluation of endocrine tests. A: the TRH test in patients with hyperprolactinaemia. Neth J Med 71:44–48
25.
go back to reference Sawers HA, Robb OJ, Walmsley D (1997) An audit of the diagnostic usefulness of prolactin and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia. Clin Endocrinol (Oxf) 46:321–326. Medline. doi:10.1046/j.1365-2265.1997.1350956.x CrossRef Sawers HA, Robb OJ, Walmsley D (1997) An audit of the diagnostic usefulness of prolactin and TSH responses to domperidone and high resolution magnetic resonance imaging of the pituitary in the evaluation of hyperprolactinaemia. Clin Endocrinol (Oxf) 46:321–326. Medline. doi:10.​1046/​j.​1365-2265.​1997.​1350956.​x CrossRef
26.
go back to reference Kamoi T, Tchuchida I, Sata H et al (1981) Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors. J Clin Endocrinol Metab 53:1285–1287. MedlinePubMed Kamoi T, Tchuchida I, Sata H et al (1981) Comparison of the responses in the nomifensine test with hyperprolactinemia due to prolactin-secreting pituitary tumors and nonprolactin-secreting hypothalamic tumors. J Clin Endocrinol Metab 53:1285–1287. MedlinePubMed
27.
go back to reference Archer DF, Josimovich JB, Maroon JC (1977) Chlorpromazine-induced changes in serum prolactin in women with oligomenorrhea, amenorrhea and pituitary adenoma. Fertil Steril 28:1164–1167. MedlinePubMed Archer DF, Josimovich JB, Maroon JC (1977) Chlorpromazine-induced changes in serum prolactin in women with oligomenorrhea, amenorrhea and pituitary adenoma. Fertil Steril 28:1164–1167. MedlinePubMed
28.
go back to reference Tucker HG, Lankford HV, Gardner DF et al (1980) Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with galactorrhea-amenorrhea syndrome. J Clin Endocrinol Metab 51:968–971. MedlinePubMed Tucker HG, Lankford HV, Gardner DF et al (1980) Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with galactorrhea-amenorrhea syndrome. J Clin Endocrinol Metab 51:968–971. MedlinePubMed
30.
go back to reference Molitch ME, Goodman RH, Post KD et al (1982) Surgical cure of prolactinoma reverses abnormal prolactin response to carbidopa/l-dopa. J Clin Endocrinol Metab 55:1118–1123. MedlinePubMed Molitch ME, Goodman RH, Post KD et al (1982) Surgical cure of prolactinoma reverses abnormal prolactin response to carbidopa/l-dopa. J Clin Endocrinol Metab 55:1118–1123. MedlinePubMed
31.
go back to reference Vance ML, Thorner MO (1987) Prolactinomas. Endocrinol Metab Clinics N Amer 16:731–753 Vance ML, Thorner MO (1987) Prolactinomas. Endocrinol Metab Clinics N Amer 16:731–753
33.
go back to reference Suh HK, Frantz AG (1974) Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 39:928–935. MedlinePubMed Suh HK, Frantz AG (1974) Size heterogeneity of human prolactin in plasma and pituitary extracts. J Clin Endocrinol Metab 39:928–935. MedlinePubMed
34.
go back to reference Farkouh NH, Packer MG, Frantz AG (1979) Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone. J Clin Endocrinol Metab 48:1026–1032. MedlinePubMed Farkouh NH, Packer MG, Frantz AG (1979) Large molecular size prolactin with reduced receptor activity in human serum: high proportion in basal state and reduction after thyrotropin-releasing hormone. J Clin Endocrinol Metab 48:1026–1032. MedlinePubMed
35.
go back to reference Hattori N, Inagaki C (1997) Anti-prolactin autoantibodies cause asymptomatic hyperprolactinemia :bioassay and clearance studies of prolactin-immunoglobulin G complex. J Clin Endocrinol Metab 82:3107–3110. Medline. doi:10.1210/jc.82.9.3107 PubMedCrossRef Hattori N, Inagaki C (1997) Anti-prolactin autoantibodies cause asymptomatic hyperprolactinemia :bioassay and clearance studies of prolactin-immunoglobulin G complex. J Clin Endocrinol Metab 82:3107–3110. Medline. doi:10.​1210/​jc.​82.​9.​3107 PubMedCrossRef
36.
go back to reference Fahie-Wilson M, Soule S (1997) Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 34:252–258, MedlinePubMed Fahie-Wilson M, Soule S (1997) Macroprolactinaemia: contribution to hyperprolactinaemia in a district general hospital and evaluation of a screening test based on precipitation with polyethylene glycol. Ann Clin Biochem 34:252–258, MedlinePubMed
38.
go back to reference Leslie H, Courtney C, Bell P et al (2001) A Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 86:2743–2746. Medline. doi:10.1210/jc.86.6.2743 PubMedCrossRef Leslie H, Courtney C, Bell P et al (2001) A Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method. J Clin Endocrinol Metab 86:2743–2746. Medline. doi:10.​1210/​jc.​86.​6.​2743 PubMedCrossRef
40.
go back to reference Suliman AM, Smith TP, Gibney J et al (2003) Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 49:1504–1509. Medline. doi:10.1373/49.9.1504 PubMedCrossRef Suliman AM, Smith TP, Gibney J et al (2003) Frequent misdiagnosis and mismanagement of hyperprolactinemic patients before the introduction of macroprolactin screening: application of a new strict laboratory definition of macroprolactinemia. Clin Chem 49:1504–1509. Medline. doi:10.​1373/​49.​9.​1504 PubMedCrossRef
41.
go back to reference Molitch ME, Russell EJ (1990) The pituitary ‘incidentaloma’. Ann Intern Med 112:925–931. MedlinePubMed Molitch ME, Russell EJ (1990) The pituitary ‘incidentaloma’. Ann Intern Med 112:925–931. MedlinePubMed
42.
go back to reference Smith TP, Suliman AM, Fahie-Wilson MN et al (2002) Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 87:5410–5415. Medline. doi:10.1210/jc.2001-011943 PubMedCrossRef Smith TP, Suliman AM, Fahie-Wilson MN et al (2002) Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays. J Clin Endocrinol Metab 87:5410–5415. Medline. doi:10.​1210/​jc.​2001-011943 PubMedCrossRef
43.
go back to reference Pinto LP, Hanna FWF, Evans LM, Davies JS, John R, Scanlon MF (2003) The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia. Clin Endocrinol (Oxf) 59:580–584. Medline. doi:10.1046/j.1365-2265.2003.01887.x CrossRef Pinto LP, Hanna FWF, Evans LM, Davies JS, John R, Scanlon MF (2003) The TSH response to domperidone reflects the biological activity of prolactin in macroprolactinaemia and hyperprolactinaemia. Clin Endocrinol (Oxf) 59:580–584. Medline. doi:10.​1046/​j.​1365-2265.​2003.​01887.​x CrossRef
46.
go back to reference Molitch M (2005) Medication-induced hyperprolactinemia. Mayo Clin Proc 80:1050–1057 MedlinePubMed Molitch M (2005) Medication-induced hyperprolactinemia. Mayo Clin Proc 80:1050–1057 MedlinePubMed
47.
go back to reference Lim VS, Kathpalia S, Frohman LA (1979) Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation. J Clin Endocrinol Metab 48:101–107 MedlinePubMed Lim VS, Kathpalia S, Frohman LA (1979) Hyperprolactinemia and impaired pituitary response to suppression and stimulation in chronic renal failure: reversal after transplantation. J Clin Endocrinol Metab 48:101–107 MedlinePubMed
50.
52.
go back to reference Serri O, Chik CL, Ur E et al (2003) Diagnosis and management of hyperprolactinemia. CMAJ 169:575–581. MedlinePubMed Serri O, Chik CL, Ur E et al (2003) Diagnosis and management of hyperprolactinemia. CMAJ 169:575–581. MedlinePubMed
55.
go back to reference Karavitaki Ni Thanabalasingham G, Shore HCA, Trifanescu R, Ansorge O, Meston N, Turner H, Wass JAH (2006) Do the limits of serum prolactin in disconnection hyperprolactinemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 65:524–529. Medline. doi:10.1111/j.1365-2265.2006.02627.x CrossRef Karavitaki Ni Thanabalasingham G, Shore HCA, Trifanescu R, Ansorge O, Meston N, Turner H, Wass JAH (2006) Do the limits of serum prolactin in disconnection hyperprolactinemia need re-definition? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endocrinol (Oxf) 65:524–529. Medline. doi:10.​1111/​j.​1365-2265.​2006.​02627.​x CrossRef
56.
go back to reference Schlechte J, Dolan K, Sherman B et al (1989) The natural history of untreated hyperprolactinemia; a prospective analysis. J Clin Endocrinol Metab 68:412–418. MedlinePubMedCrossRef Schlechte J, Dolan K, Sherman B et al (1989) The natural history of untreated hyperprolactinemia; a prospective analysis. J Clin Endocrinol Metab 68:412–418. MedlinePubMedCrossRef
58.
go back to reference Kauppila A, Chatelaiin P, Kirkinen P (1987) Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab 64:309–312. MedlinePubMed Kauppila A, Chatelaiin P, Kirkinen P (1987) Isolated prolactin deficiency in a woman with puerperal alactogenesis. J Clin Endocrinol Metab 64:309–312. MedlinePubMed
60.
go back to reference Toledano Y, Lubetsky A, Shimon I (2007) Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest 30:268–273. MedlinePubMed Toledano Y, Lubetsky A, Shimon I (2007) Acquired prolactin deficiency in patients with disorders of the hypothalamic-pituitary axis. J Endocrinol Invest 30:268–273. MedlinePubMed
Metadata
Title
Hyperprolactinemia
Authors
Jaspreet Chahal
Janet Schlechte
Publication date
01-06-2008
Publisher
Springer US
Published in
Pituitary / Issue 2/2008
Print ISSN: 1386-341X
Electronic ISSN: 1573-7403
DOI
https://doi.org/10.1007/s11102-008-0107-5

Other articles of this Issue 2/2008

Pituitary 2/2008 Go to the issue

OriginalPaper

Drugs and prolactin

OriginalPaper

Drugs and HPA axis

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine